Sun Pharma, Aurobindo recall drugs from US market

As per the USFDA, a Class III recall is initiated in a "situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences". The US health regulator stated that Aurobindo Pharma is recalling 9,890 bottles of Rasagiline Tablets, a medication indicated for the treatment of Parkinson's disease, from the US.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/gqPdDV2
via gqrds

Singapore experiencing another COVID-19 wave: Health minister warns

The spate of these recent cases is driven by mostly two variants - the EG.5 and its sub-lineage HK.3 - both of which are descendants of the XBB Omicron variant.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/ZtdU42F
via gqrds

More than 75,000 US health care workers begin 3-day strike

The walkout of more than 75,000 workers at Kaiser Permanente, the country's largest non-profit health care organisation, comes as surging inflation has spurred industrial action across the US, from Hollywood actors to Detroit auto workers.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/t8OLBNV
via gqrds

MediBuddy’s workplace data underscores vital role of early diagnosis in diabetes management

India accounts for one in seven of all adults living with diabetes globally. Accessibility to high-quality healthcare through telemedicine can help facilitate the uptake of preventive care and further lower health risks, especially in developing countries with a skewed doctor-to-patient ratio.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/LHKc2x8
via gqrds

Malaria vaccine co-developed by Serum Institute will bridge supply gap: Adar Poonawalla

As malaria vaccine developed by the University of Oxford and the Serum Institute of India (SII) has been recommended for use by the World Health Organisation (WHO), SII chief Adar Poonawalla said that the combined efforts of both of them have come to fruition.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/2mxdMwS
via gqrds

Drugmakers sign on to negotiate Medicare prices under protest

The penalties for not doing so would have been steep: drugmakers would have to pay 65 per cent to 95 per cent taxes on their drug's Medicare sales or withdraw all of their products from the Medicare and Medicaid programs, which together provide health benefits to 158 million Americans.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/r8GxjU2
via gqrds

AstraZeneca India gets CDSCO approval for 'Palivizumab' preventive therapy against respiratory syncytial virus

RSV poses a significant global public health challenge, particularly affecting children, and stands as the second most common cause of death in infants under one year of age, following only malaria. The World Health Organisation (WHO) estimates that RSV accounts for over 60 per cent of acute respiratory infections in children and more than 80 per cent in infants under one year old.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/cqukMN6
via gqrds